Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Foamix Earns $2.5M Bayer Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Foamix Earns $2.5M Bayer Milestone

License agreement includes foam vehicle for Azelaic Acid

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Foamix Pharmaceuticals has received a $2.5 million milestone payment under a license agreement with Bayer HealthCare. Foamix is entitled to royalties and further milestone payments under certain conditions. Terms of the agreement were not disclosed.
 
Under the agreement, Bayer has licensed a foam vehicle from Foamix for its compound azelaic acid. Azelaic Acid Foam 15% is currently in Phase III development for the treatment of Rosacea.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics